Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Lehmann

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Applied Clinical Medical Physics|May 16, 2023
A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot studyMitsuhiro Nakamura, Dejun Zhou, Toshiyuki Minemura, et al.
Journal of Applied Clinical Medical Physics|May 29, 2025
Developing reference plans for evaluating global clinical trials credentialing and PSQA systemsFre'Etta M D Brooks, Mohammad Hussein, Jessica Lye, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2026
A comparison of sensitivity and specificity of dosimetry audits for intensity modulated radiation therapy used internationally for clinical trial credentialingFre'Etta Brooks, Joerg Lehmann, Mohammad Hussein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyStephen F Kry, Jessica Lye, Catharine H Clark, et al.
Ecancermedicalscience|April 28, 2023
Challenges and opportunities for implementing hypofractionated radiotherapy in Africa: lessons from the HypoAfrica clinical trialElizabeth Olatunji, William Swanson, Saloni Patel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 28, 2023
Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparisonPaige A Taylor, Elizabeth Miles, Lone Hoffmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2022
SEAFARER - A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practiceJoerg Lehmann, Mohammad Hussein, Miriam A Barry, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2020
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelinesRomaana Mir, Sarah M Kelly, Ying Xiao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2026
It's not your device, it's how you use it - Sensitivity and specificity of PSQA devices in the SEAFARER head and neck studyLauren May, José Antonio Baeza-Ortega, Mohammad Hussein, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Applied Clinical Medical Physics|May 16, 2023
A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot studyMitsuhiro Nakamura, Dejun Zhou, Toshiyuki Minemura, et al.
Journal of Applied Clinical Medical Physics|May 29, 2025
Developing reference plans for evaluating global clinical trials credentialing and PSQA systemsFre'Etta M D Brooks, Mohammad Hussein, Jessica Lye, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2026
A comparison of sensitivity and specificity of dosimetry audits for intensity modulated radiation therapy used internationally for clinical trial credentialingFre'Etta Brooks, Joerg Lehmann, Mohammad Hussein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyStephen F Kry, Jessica Lye, Catharine H Clark, et al.
Ecancermedicalscience|April 28, 2023
Challenges and opportunities for implementing hypofractionated radiotherapy in Africa: lessons from the HypoAfrica clinical trialElizabeth Olatunji, William Swanson, Saloni Patel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 28, 2023
Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparisonPaige A Taylor, Elizabeth Miles, Lone Hoffmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2022
SEAFARER - A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practiceJoerg Lehmann, Mohammad Hussein, Miriam A Barry, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2020
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelinesRomaana Mir, Sarah M Kelly, Ying Xiao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2026
It's not your device, it's how you use it - Sensitivity and specificity of PSQA devices in the SEAFARER head and neck studyLauren May, José Antonio Baeza-Ortega, Mohammad Hussein, et al.
Pageof 7